Personal information

Websites & social links

LinkedIn

Other IDs

Loop profile: 1508792

Activities

Collapse all

Employment (6)

Netherlands Cancer Institute: Amsterdam, NL

2019 to present | PhD student (Molecular Carcinogenesis)
Employment
Source: Self-asserted source
0000-0003-0643-6676

The Hyve: Utrecht, NL

2018 to 2019 | Bioinformatician
Employment
Source: Self-asserted source
0000-0003-0643-6676

Vrije Universiteit Amsterdam: Amsterdam, NL

2017-03 to 2018-09 | Teacher assistant (Bioinformatics, Python programming, Machine learning)
Employment
Source: Self-asserted source
0000-0003-0643-6676

Netherlands Cancer Institute (NKI): Amsterdam, Noord-Holland, NL

2018 to 2018 | Bioinformatics Intern (Molecular Pathology)
Employment
Source: Self-asserted source
0000-0003-0643-6676

Edgeleap: Utrecht, NL

2017 to 2017 | Data science intern
Employment
Source: Self-asserted source
0000-0003-0643-6676

ICFO - The Institute of Photonic Sciences: Castelldefels, ES

2015 to 2015 | Summer fellow
Employment
Source: Self-asserted source
0000-0003-0643-6676

Education and qualifications (5)

Delft University of Technology: Delft, Zuid-Holland, NL

2019 to present | PhD Degree
Education
Source: Self-asserted source
0000-0003-0643-6676

Vrije Universiteit Amsterdam: Amsterdam, Noord-Holland, NL

2016 to 2018 | MSc Bioinformatics and Systems Biology
Education
Source: Self-asserted source
0000-0003-0643-6676

University of Amsterdam: Amsterdam, Noord-Holland, NL

2016 to 2018 | MSc Bioinformatics and Systems Biology
Education
Source: Self-asserted source
0000-0003-0643-6676

Universitat Autònoma de Barcelona : Barcelona, Catalunya, ES

2011 to 2016 | BSc Physics
Education
Source: Self-asserted source
0000-0003-0643-6676

Universitat Autònoma de Barcelona: Barcelona, Catalunya, ES

2011 to 2016 | BSc Chemistry
Education
Source: Self-asserted source
0000-0003-0643-6676

Professional activities (3)

International Society for Computational Biology: Bethesda, Maryland, US

Membership
Source: Self-asserted source
0000-0003-0643-6676

CENL - Spanish Scientists in the Netherlands: Utrecht, NL

Member
Membership
Source: Self-asserted source
0000-0003-0643-6676

American Association for Cancer Research: PA, PA, US

Associate member
Membership
Source: Self-asserted source
0000-0003-0643-6676

Funding (1)

Spatial Transcriptomics Technology Access pilot

Grant
Oncode Institute (Utrecht, NL)
URL: https://www.oncode.nl/research/programs/technology-access
Source: Self-asserted source
0000-0003-0643-6676

Works (6)

Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer

European Urology
2023-04 | Journal article | Author
DOI: 10.1016/j.eururo.2022.07.023
Part of ISSN: 0302-2838
Contributors: 0000-0003-0643-6676; Jeroen van Dorp; Alberto Contreras-Sanz; Kristan van der Vos; Daniel J. Vis; Linde Braaf; Annegien Broeks; Ron Kerkhoven; Kim E.M. van Kessel; María José Ribal et al.
Source: Self-asserted source
0000-0003-0643-6676

Abstract 1273: Predicting pathological response after ipilimumab plus nivolumab in stage III urothelial cancer by liquid-biopsy assessment of plasma and urine ctDNA using the RaDaR assay

Cancer Research
2022-06-15 | Conference abstract
DOI: 10.1158/1538-7445.am2022-1273
Part of ISSN: 1538-7445
Contributors: Jeroen van Dorp; Christodoulos Pipinikas; Nick van Dijk; Greg Jones; Alberto Gil-Jimenez; Giovanni Marsico; Maurits L. van Montfoort; Sophie Hackinger; Linde Braaf; Kirsten McLay et al.
Source: Self-asserted source
0000-0003-0643-6676

T Cell-to-Stroma Enrichment (TSE) score: a gene expression metric that predicts response to immune checkpoint inhibitors in patients with urothelial cancer

2022-05-31 | Preprint
DOI: 10.1101/2022.05.30.493997
Contributors: Maud Rijnders; J. Alberto Nakauma-González; Debbie G.J. Robbrecht; Alberto Gil-Jimenez; Maureen J.B. Aarts; Joost L. Boormans; Paul Hamberg; Michiel S. van der Heijden; Bernadett E. Szabados; Geert J.L.H. van Leenders et al.
Source: Self-asserted source
0000-0003-0643-6676

The Tumor Immune Landscape and Architecture of Tertiary Lymphoid Structures in Urothelial Cancer.

Frontiers in immunology
2021-12 | Journal article
DOI: 10.3389/fimmu.2021.793964
PMID: 34987518
Contributors: van Dijk N; Gil-Jimenez A; Silina K; van Montfoort ML; Einerhand S; Jonkman L; Voskuilen CS; Peters D; Sanders J; Lubeck Y et al.
Source: Self-asserted source
0000-0003-0643-6676 via Europe PubMed Central

Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial

Nature Medicine
2020-12 | Journal article
DOI: 10.1038/s41591-020-1085-z
Part of ISSN: 1078-8956
Part of ISSN: 1546-170X
Source: Self-asserted source
0000-0003-0643-6676

Biomarker analysis and updated clinical follow-up of preoperative ipilimumab (ipi) plus nivolumab (nivo) in stage III urothelial cancer (NABUCCO).

Journal of Clinical Oncology
2020-05-20 | Conference abstract
DOI: 10.1200/jco.2020.38.15_suppl.5020
Part of ISSN: 0732-183X
Part of ISSN: 1527-7755
Contributors: Nick Van Dijk; Alberto Gil Jimenez; Karina Silina; Kees Hendricksen; Laura Smit; Jeantine De Feijter; Maurits L van Montfoort; Annegien Broeks; Yoni Lubeck; Karolina Sikorska et al.
Source: Self-asserted source
0000-0003-0643-6676
How many people are using ORCID?